Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice

Mol Nutr Food Res. 2019 May;63(9):e1801307. doi: 10.1002/mnfr.201801307. Epub 2019 Feb 25.

Abstract

Scope: Published data support that gut microbiota play an important role in the pathological process of obesity and related metabolic disorders. In the current study, it is investigated whether a standardized extract from Jamun (Eugenia jambolana), a widely consumed tropical fruit, could alleviate obesity and alter gut microbial community in high-fat diet (HFD)-fed mice.

Methods and results: C57BL/6 mice are fed either a standard diet (SD) or HFD with or without Jamun fruit extract (JFE; 100 mg kg-1 day-1 ) by oral gavage for 8 weeks. JFE supplementation significantly alleviated diet-induced obesity, insulin resistance, and liver steatosis. JFE supplementation also improved HFD-induced gut dysbiosis by restoring the ratio of Firmicutes to Bacteroidetes as revealed by 16S rDNA analyses. The relative abundance of certain genera, as well as levels and proportion of intestinal-derived short-chain fatty acids are improved in JFE-treated mice in comparison to the HFD-fed control group.

Conclusion: These promising data show the potential association between gut microbiota modulation and metabolism improvement of the JFE administration, and support the utilization and further investigation of Jamun fruit as a dietary intervention strategy for the prevention of obesity and related metabolic disorders.

Keywords: Eugenia jambolana; SCFA; gut microbiota; high-fat diet; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Body Weight / drug effects
  • Colon / drug effects
  • Colon / metabolism
  • Diet, High-Fat / adverse effects*
  • Dietary Supplements
  • Energy Intake / drug effects
  • Fatty Acids, Volatile / metabolism
  • Fruit / chemistry
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology
  • Insulin Resistance
  • Lipids / blood
  • Male
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / prevention & control*
  • Obesity / prevention & control*
  • Plant Extracts / pharmacology
  • Syzygium / chemistry*

Substances

  • Anti-Obesity Agents
  • Fatty Acids, Volatile
  • Lipids
  • Plant Extracts